Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
22.60
+0.11 (0.49%)
Jan 30, 2025, 4:00 PM EST - Market closed
Rigel Pharmaceuticals Employees
Rigel Pharmaceuticals had 147 employees as of December 31, 2023. The number of employees decreased by 8 or -5.16% compared to the previous year.
Employees
147
Change (1Y)
-8
Growth (1Y)
-5.16%
Revenue / Employee
$1,070,571
Profits / Employee
$26,401
Market Cap
398.10M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
RIGL News
- 8 days ago - Rigel's Fostamatinib Being Studied by National Institute of Health in Patients with Sickle Cell Disease - PRNewsWire
- 17 days ago - Rigel Provides Business Update and 2025 Outlook - PRNewsWire
- 21 days ago - Rigel Announces R289 Granted Orphan Drug Designation by the FDA for MDS - PRNewsWire
- 22 days ago - Rigel to Present at the 43rd Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 27 days ago - Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - PRNewsWire
- 4 weeks ago - Rigel Pharmaceuticals: Realizing The Promise Of Its Acquired Pipeline Agents - Seeking Alpha
- 7 weeks ago - Rigel Highlights Initial Data from Ongoing Phase 1b Study Evaluating R289 in LR-MDS at the 66th ASH Annual Meeting and Exposition - PRNewsWire
- 2 months ago - Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS - PRNewsWire